China's NeuroXess raised 700 million yuan in a Series B round for implantable brain-computer interfaces
Prepared by Sintelligent with the help of SI. Published in SI: . Updated: .
A Chinese developer of an implantable brain-computer interface has received 700 million yuan for trials and production.
SDIC Juli, Shenzhen Capital Group and Qinzhi Capital jointly led the 700-million-yuan Series B round; the funds will go to multicenter clinical trials, regulatory filings, expanded production and development of the next generation of the product. NeuroXess makes implantable systems with flexible electrodes and wireless transmission of power and data; the system is designed to decode movement and speech and to control external devices. The company reported 65 clinical cases and the start in July of a registration study in nearly 20 hospitals; it is building a 14,300-square-meter plant with a design capacity of 10,000 systems a year. According to TechNode, citing PEdaily.
Sources 1